Department of Thoracic Surgery, National Clinical Research Center for Cancer/Cancer Hospital, National Cancer Center, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Nanli 17, Panjiayuan, Beijing, 100021, People's Republic of China.
Sci Rep. 2024 Sep 27;14(1):22045. doi: 10.1038/s41598-024-73486-6.
The prognosis of poorly differentiated lung adenocarcinoma (PDLA) is determined by many clinicopathological factors. The aim of this study is identifying prognostic factors and developing reliable nomogram to predict the overall survival (OS) and cancer-specific survival (CSS) in patients with PDLA. Patient data from the Surveillance, Epidemiology and End Results (SEER) database was collected and analyzed. The SEER database was used to screen 1059 eligible patients as the study cohort. The whole cohort was randomly divided into a training cohort (n = 530) and a test cohort (n = 529). Cox proportional hazards analysis was used to identify variables and construct a nomogram based on the training cohort. C-index and calibration curves were performed to evaluate the performance of the model in the training cohort and test cohorts. For patients with PDLA, age at diagnosis, gender, tumor size were independent prognostic factors both for overall survival (OS) and cancer-specific survival (CSS), while race and number of nodes were specifically related to OS. The calibration curves presented excellent consistency between the actual and nomogram-predict survival probabilities in the training and test cohorts. The C-index values of the nomogram were 0.700 and 0.730 for OS and CSS, respectively. The novel nomogram provides new insights of the risk of each prognostic factor and can assist doctors in predicting the 1-year, 3-year and 5-year OS and CSS in patients with PDLA.
低分化肺腺癌(PDLA)的预后由许多临床病理因素决定。本研究旨在确定预后因素,并开发可靠的列线图来预测 PDLA 患者的总生存期(OS)和癌症特异性生存期(CSS)。从监测、流行病学和最终结果(SEER)数据库中收集并分析了患者数据。该 SEER 数据库用于筛选 1059 名符合条件的患者作为研究队列。整个队列被随机分为训练队列(n=530)和测试队列(n=529)。Cox 比例风险分析用于确定变量,并根据训练队列构建列线图。使用 C 指数和校准曲线来评估模型在训练队列和测试队列中的性能。对于 PDLA 患者,诊断时的年龄、性别、肿瘤大小是总生存期(OS)和癌症特异性生存期(CSS)的独立预后因素,而种族和淋巴结数量则与 OS 具体相关。校准曲线在训练和测试队列中均呈现出实际和列线图预测生存率之间的极好一致性。该列线图的 C 指数值分别为 OS 和 CSS 的 0.700 和 0.730。该新列线图提供了每个预后因素风险的新见解,并可以帮助医生预测 PDLA 患者的 1 年、3 年和 5 年 OS 和 CSS。